Registered entities
Eureka Therapeutics Inc
Reg. No. 204354368United States
Eureka Therapeutics, Inc
Reg. No. 6700219United States
Innovation
52 patent families (27 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 12,374 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 21 |
| 2017 | 18 |
| 2018 | 26 |
| 2019 | 24 |
| 2020 | 23 |
| 2021 | 21 |
| 2022 | 26 |
| 2023 | 20 |
| 2024 | 17 |
| 2025 | 14 |
| 2026 | 3 |
Social engagement
Social engagement: 6.4K social following, 9 posts in the last 12 months — around the industry typical range.
Investor mix
12 investors on record; lead investors include Lyell Immunopharma, Yuan Capital, Acorn Pacific Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 67% |
| Private equity | 1 | 8% |
| Other / undisclosed | 3 | 25% |
Recent activity
4 May 2026
Event
Free webinar on grief
16 Feb 2026
Event
Hepatoblastoma Webinar
5 Feb 2026
Event
HCC-Live at the Regency